Mangoceuticals, Inc.
MGRX
$4.91
-$0.37-7.01%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 16.39% | -0.99% | 7.80% | -42.71% | 21.21% |
| Total Depreciation and Amortization | -90.63% | -48.39% | -1.59% | 0.00% | 1.61% |
| Total Amortization of Deferred Charges | 8.49% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.31% | 93.09% | -42.34% | 309.56% | -56.57% |
| Change in Net Operating Assets | 93.09% | -131.62% | 1,105.00% | 169.09% | -302.95% |
| Cash from Operations | 26.08% | -59.14% | 41.62% | 0.76% | 3.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | 14.29% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -100.00% | 115.72% | -85.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -50.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -62.28% | 643.29% | -77.71% | -- | -100.00% |
| Foreign Exchange rate Adjustments | 54.55% | -1,000.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -187.66% | 165.62% | -45.41% | 70.91% | -85.24% |
